Clinical Trials Sponsored by Lee Blonder

Total 1940 results

H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Metastatic Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Melanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage III

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Metastatic Castration-resistant Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Senior Adult Hepatobiliary Prehab Study

Cholangiocarcinoma | Liver Metastases | Hepatobiliary Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Nonsmall Cell Lung Cancer | Nonsmall Cell Lung Cancer Stage III | Unresectable Non-Small Cell Lung Carcinoma | Nonsmall Cell Lung Cancer, Stage II

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Non Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Non Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Adenocarcinoma of Lung | Lung; Node

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients (STRONG-GEC)

GastroEsophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Merkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Preop fSRS for Resectable Brain Metastases

Brain Metastases | Brain Lesion

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies

Surgical Wound Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Intermittent Fasting for Pancreatitis (IFPanc)

Pancreatitis | Pancreatitis, Chronic | Pancreatitis, Acute | Pancreas Disease | Acute Recurrent Pancreatitis

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Follicular Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Diffuse Large-Cell Lymphoma | Transformed Follicular Lymphoma (TFL) | High-grade B-cell Lymphoma (HGBCL)

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Incurable Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Modifying Diet to Improve Gut Microbiome

Obesity

United States
Ho Sup Lee
Takeda

Recruiting

Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Mantle Cell Lymphoma

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Skin Cancer | Melanoma (Skin) | Skin Carcinoma | Skin Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Validation Study on the Impact of Decipher® Testing - VANDAAM Study (VANDAAM)

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy (Neoadjuvant)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator

Brain Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Florida Pancreas Collaborative Next Generation Biobank

Pancreatic Cancer | Cancer Cachexia

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

Lung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center

Gynecologic Cancer | Prostate Cancer | Patient Satisfaction

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study

Cutaneous Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors

Cancer Survivor | Young Adult

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer

Breast Cancer | Breast Cancer Female | Breast Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life (C-PRIME)

Quality of Life | Stress | Sleep Disturbance

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

Hyperglycemia

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Addressing Barriers to Palliative Care Use in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IV

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease

Graft Versus Host Disease

United States
CHEOL WHAN LEE, M.D., Ph.D

Terminated

Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease

Coronary Artery Disease | Prediabetic State

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Completed

Colorectal Cancer Awareness, Research, Education and Screening (CARES)

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Breast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein Overexpression

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluating Biobanking Educational Tools

Neoplasm

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Thyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer

Liver Cancer | Hepatocellular Cancer

United States
Sang Yeoup Lee

Completed

Ulmus Macrocarpa Hance Extract and Lipid Profile

Dyslipidemias

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Breast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, Female

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer

Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute

Completed

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

Small Cell Lung Cancer

United States
Dr. Gillian Lee

Unknown

Is Xylitol Toothpaste Effective in Preventing Tooth Decay?

Dental Caries

China
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Lung Cancer | Adenocarcinoma of the Lung

Clinical Trials Sponsored by Lee Blonder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations